These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 10371335)
1. Prognostic value of CD44 variant expression in primary breast cancer. Foekens JA; Dall P; Klijn JG; Skroch-Angel P; Claassen CJ; Look MP; Ponta H; Van Putten WL; Herrlich P; Henzen-Logmans SC Int J Cancer; 1999 Jun; 84(3):209-15. PubMed ID: 10371335 [TBL] [Abstract][Full Text] [Related]
2. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer. Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795 [TBL] [Abstract][Full Text] [Related]
3. CD44 variant exon epitopes in primary breast cancer and length of survival. Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P Lancet; 1995 Mar; 345(8950):615-9. PubMed ID: 7534855 [TBL] [Abstract][Full Text] [Related]
4. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of CD44 splice variants in human stage III cervical cancer. Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429 [TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 variants in osteosarcoma. Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973 [TBL] [Abstract][Full Text] [Related]
7. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells. Bendall LJ; Bradstock KF; Gottlieb DJ Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548 [TBL] [Abstract][Full Text] [Related]
8. Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis. Lackner C; Moser R; Bauernhofer T; Wilders-Truschnig M; Samonigg H; Berghold A; Zatloukal K Breast Cancer Res Treat; 1998 Jan; 47(1):29-40. PubMed ID: 9493973 [TBL] [Abstract][Full Text] [Related]
9. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas. Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106 [TBL] [Abstract][Full Text] [Related]
10. A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer. Schumacher U; Horny HP; Horst HA; Herrlich P; Kaiserling E Eur J Surg Oncol; 1996 Jun; 22(3):259-61. PubMed ID: 8654608 [TBL] [Abstract][Full Text] [Related]
11. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma. Ermak G; Jennings T; Robinson L; Ross JS; Figge J Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758 [TBL] [Abstract][Full Text] [Related]
12. CD44 expression in soft tissue sarcomas. Kahara N; Ozaki T; Doi T; Nishida K; Kawai A; Shibahara M; Inoue H Virchows Arch; 2000 Jun; 436(6):574-8. PubMed ID: 10917171 [TBL] [Abstract][Full Text] [Related]